
Michelle M. Iacoletti
Examiner (ID: 9693, Phone: (571)270-5789 , Office: P/2882 )
| Most Active Art Unit | 2882 |
| Art Unit(s) | 2882, 4185, 4100, 2877 |
| Total Applications | 628 |
| Issued Applications | 540 |
| Pending Applications | 11 |
| Abandoned Applications | 82 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13328467
[patent_doc_number] => 20180215771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TUNABLE RARE-EARTH FCU-METAL-ORGANIC FRAMEWORKS
[patent_app_type] => utility
[patent_app_number] => 15/926511
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926511
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/926511 | Tunable rare-earth fcu-metal-organic frameworks | Mar 19, 2018 | Issued |
Array
(
[id] => 16946651
[patent_doc_number] => 20210205342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
[patent_app_type] => utility
[patent_app_number] => 16/494581
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494581 | Nicotinamide riboside for use in treating or preventing liver damage | Mar 15, 2018 | Issued |
Array
(
[id] => 13300857
[patent_doc_number] => 20180201965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => METHOD FOR PRODUCING GALACTOOLIGOSACCHARIDES FROM LACTOSE
[patent_app_type] => utility
[patent_app_number] => 15/923957
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923957
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923957 | Method for producing galactooligosaccharides from lactose | Mar 15, 2018 | Issued |
Array
(
[id] => 15618807
[patent_doc_number] => 20200079808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => GLYCOPOLYMERS SEQUESTERING CARBOHYDRATE-BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/493959
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493959 | GLYCOPOLYMERS SEQUESTERING CARBOHYDRATE-BINDING PROTEINS | Mar 14, 2018 | Abandoned |
Array
(
[id] => 12908770
[patent_doc_number] => 20180194765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING BETA-LACTAMASE
[patent_app_type] => utility
[patent_app_number] => 15/917059
[patent_app_country] => US
[patent_app_date] => 2018-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917059 | Compositions and methods for inhibiting b-lactamase | Mar 8, 2018 | Issued |
Array
(
[id] => 13957813
[patent_doc_number] => 20190055250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/914047
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 2124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914047
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914047 | Heterocyclic compounds as LSD1 inhibitors | Mar 6, 2018 | Issued |
Array
(
[id] => 19134528
[patent_doc_number] => 11969437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Alginate liquid preparation
[patent_app_type] => utility
[patent_app_number] => 16/491709
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9275
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491709 | Alginate liquid preparation | Mar 5, 2018 | Issued |
Array
(
[id] => 16673061
[patent_doc_number] => 20210061824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => SILANOL COMPOUND AND METHOD FOR PRODUCING SILANOL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/606487
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606487 | SILANOL COMPOUND AND METHOD FOR PRODUCING SILANOL COMPOUND | Mar 4, 2018 | Abandoned |
Array
(
[id] => 12880573
[patent_doc_number] => 20180185366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Inhibitors of Multidrug Resistance Transporter P-Glycoprotein
[patent_app_type] => utility
[patent_app_number] => 15/911441
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15911441
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/911441 | Inhibitors of multidrug resistance transporter P-glycoprotein | Mar 4, 2018 | Issued |
Array
(
[id] => 17586530
[patent_doc_number] => 11324772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Periodontal gel composition and method of use
[patent_app_type] => utility
[patent_app_number] => 16/487337
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 8653
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487337 | Periodontal gel composition and method of use | Feb 26, 2018 | Issued |
Array
(
[id] => 16806044
[patent_doc_number] => 20210128597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => THE HSP90 ACTIVATOR AHA1 DRIVES PRODUCTION OF PATHOLOGICAL TAU AGGREGATES
[patent_app_type] => utility
[patent_app_number] => 16/486975
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486975 | Hsp90 activator Aha1 drives production of pathological tau aggregates | Feb 22, 2018 | Issued |
Array
(
[id] => 15342555
[patent_doc_number] => 20200009169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF LIVER, LIPID, AND GLUCOSE-RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/487829
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7017
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487829 | COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF LIVER, LIPID, AND GLUCOSE-RELATED CONDITIONS | Feb 19, 2018 | Abandoned |
Array
(
[id] => 12837277
[patent_doc_number] => 20180170932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PURINE DIONES AS WNT PATHWAY MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/899675
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/899675 | Purine diones as Wnt pathway modulators | Feb 19, 2018 | Issued |
Array
(
[id] => 18932371
[patent_doc_number] => 11884779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Ionically modified silicones, compositions, and medical devices formed therefrom
[patent_app_type] => utility
[patent_app_number] => 16/482739
[patent_app_country] => US
[patent_app_date] => 2018-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11890
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 509
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482739 | Ionically modified silicones, compositions, and medical devices formed therefrom | Feb 15, 2018 | Issued |
Array
(
[id] => 12837226
[patent_doc_number] => 20180170915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => 5-BROMO-INDIRUBINS
[patent_app_type] => utility
[patent_app_number] => 15/898151
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15898151
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/898151 | 5-BROMO-INDIRUBINS | Feb 14, 2018 | Abandoned |
Array
(
[id] => 17741421
[patent_doc_number] => 11389466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Multivalent fucose derivatives for use as a drug
[patent_app_type] => utility
[patent_app_number] => 16/485899
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 23689
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 282
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485899 | Multivalent fucose derivatives for use as a drug | Feb 14, 2018 | Issued |
| 15/894118 | COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNITY | Feb 11, 2018 | Abandoned |
Array
(
[id] => 17814251
[patent_doc_number] => 11419838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
[patent_app_type] => utility
[patent_app_number] => 15/892078
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7337
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892078 | Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome | Feb 7, 2018 | Issued |
Array
(
[id] => 15265389
[patent_doc_number] => 20190381428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => Selective Polysaccharide Flocculants for Bauxite Ore Beneficiation
[patent_app_type] => utility
[patent_app_number] => 16/480547
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480547 | Selective Polysaccharide Flocculants for Bauxite Ore Beneficiation | Feb 6, 2018 | Abandoned |
Array
(
[id] => 17602865
[patent_doc_number] => 11331334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Intranasal composition of methylcobalamin
[patent_app_type] => utility
[patent_app_number] => 16/482491
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4707
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16482491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/482491 | Intranasal composition of methylcobalamin | Feb 4, 2018 | Issued |